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Aims: This study aimed at evaluating the oxidative stress inmitochondria isolated from the brain and liver ofmice
treated with riparin A, as well as the locomotor activity and myorelaxant effect of this compound. Behavioral
models of rota rod and open ﬁeld tests were used for locomotor activity and myorelaxant effect evaluation.
Main methods: The animals were divided into ﬁve groups (n = 8), which were treated with: diazepam
(1 mg/kg, i.p), riparin A (5, 10, and 20 mg/kg, o.r.) or vehicle (0.9% saline, o.r.). The oxidative stress evaluation
was carried out inmitochondria isolated from the brain and liver ofmice from ﬁve experimental groups (n=8),
whichwere treatedwith: ascorbic acid (250mg/kg; positive control), vehicle (0.9% saline; negative control) and
riparin A (5, 10 and 20 mg/kg).
Key ﬁndings: In an open ﬁeld and rota rod test a signiﬁcant difference in the number of crossings, in time of
permanence on the swivel bar and in the number of falls in riparin A treated animals (5, 10 and 20 mg/kg)
was not observed, when compared with negative control (vehicle) (p N 0.05). In comparison to the negative
control, there was a reduction of lipid peroxidation levels and nitrite content in mice treated with riparin A
(p b 0.05). Reduced glutathione (GSH) levels (p b 0.05), superoxide dismutase (SOD) and catalase activities
increased in the brain (rip A 5 mg/kg; p b 0.05), while in the liver SOD remained unchanged (p N 0.05) and
catalase activity (p b 0.05) was reduced.
Signiﬁcance: Riparin A was presented as a bioactive molecule devoid of adverse effects of alteration of motor
activity.© 2014 Elsevier Inc. All rights reserved.Introduction
Oxidative stress is often deﬁned as an imbalance between pro-
oxidants and antioxidants [42]. Reactive oxygen species (ROS), whether
produced endogenously as a consequence of normal cell function or
provoked by external interference, represent a constant threat to living
cells because in an aerobic environment, ROS can cause damage to DNA,
protein and lipids. Cells contain a series of antioxidant defenses to
minimize the ﬂuctuations of ROS, but the generation of ROS frequently
exceeds the cell antioxidant capacity, resulting in a condition deﬁned
as oxidative stress. It can be observed in several diseases, such as neuro-
degenerative diseases [3,15,44].Experimental Neurochemistry,
0 Teresina, PI, Brazil. Tel.: +55
s),
z@yahoo.com.br
vmendes@hotmail.comThemitochondrion is an organelle that, with use of oxygen from cel-
lular respiration, converts food energy into chemical energy (ATP),
which is vital to cell activities. A small fraction of oxygen we breathe
turns, in respiratory chain of mitochondria in reactive oxygen, a type
of free radical. The primary production of ROS occurs in the mitochon-
drion making it vulnerable to oxidative damage, and playing an impor-
tant role in controlling neuronal excitability [46].
Mitochondrial dysfunction can result in inhibition of complex I of the
mitochondrial respiratory chain,whichmay impair the efﬁciency of ATP
production by oxidative phosphorylation activity, resulting in increased
production of the superoxide molecule with consequent mitochondrial
cell death [25,38]. Changes in energy metabolism, and oxidative stress
are directly linked to chronic diseases such as cardiovascular and neuro-
logical diseases, diabetes and cancer.
The process of discovering and developing new drugs includes vari-
ous strategies and a combination of methods and drug design, begin-
ning with the understanding that chemical systems have a decisive
role in themodulation of biological systems [4], and that understanding
stimulates research and development of novel antioxidant drugs for
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oxidative stress [42].
In this context, there are some alkaloids of the alkamide group that
were isolated from the green fruit of Aniba riparia (Nees) Mez
(Lauraceae). In preclinical trials these alkaloids presented anxiolytic
and anticonvulsant effects and fewer side effects than classical medi-
cines with the same therapeutic use [43]. Through the Schotten–
Baumann reaction new riparin derivatives were prepared, named
riparin A and B, and by condensation of metallic esters with substituted
phenethylamines, riparins C, D, E and F were obtained. The riparin ana-
logs were obtained using a simple method with reliable results and
feasible commercialization of these molecules by the pharmaceutical
industry, regardless of the concentration of these selected substances
in natural sources [20].
These riparin analogs were previously submitted to in vitro assays to
investigate their antioxidant potential. It was found that these com-
pounds are very promising in antioxidant activity, mainly riparin A,
which was capable of decreasing the levels of free radicals even in low
concentrations [30]. Riparin A is constituted by a chemical structure
that is the basic structure of the other synthesized molecules of this
group and by the analysis of its molecular structure it is probable that
the antioxidant potential observed in vitro is related to the presence of
unstable hydrogen that is captured by the free radicals, inactivating
them.
The structurally suggested antioxidant potential for riparin A and its
results in the evaluation of in vitro antioxidant activity are a stimulus to
the research of its pharmacological activity and safety, prospecting a
new active principle for the development of drugs with greater safety
and fewer side effects than those currently marketed.
This study aimed at evaluating the effects of riparin A against the
oxidative stress in samples of mitochondria isolated from the brain
and liver of mice, as well as the preclinical evaluation of the locomotor
activity and myorelaxant effect of this compound.
Material and methods
Riparin A obtention
Riparin A (N-phenethylbenzamide) was obtained by a simple and
safe synthesis route, using the Schotten–Baumann reaction, described
previously in literature [20]. The substanceswere provided by Laborato-
ry Chemistry of Bioactive Natural and Synthetic Products, Federal
University of Piauí, Teresina, PI, Brazil (Scheme 1).
The analysis of the compound obtained was made through thin-
layer chromatography (TLC), which revealed a Riparin A 93.33% pure,
with yield of 84%. When subjected to the trial with Dragendoff reagent
it revealed an orange spot, qualifying it as a positive test for alkaloids
[26,41]. Its 1H NMR and 13C NMR spectra were obtained and compared
with data in literature for identiﬁcation purposes. Riparin A's melting
point is 115 °C, and the value of TLC in CH2Cl2:MeOH (99:01), with
retention fator = 0.76. The description for the 1H NMR spectrum is:
1H NMR (DMSO-d6, 500 MHz), δH 7.85 (d J = 7.4; 2H; H-2.6); 7.46
(t J= 7.3; 2H, H-3.5); 7.51 (1H, H-4); 7.25 (d J= 7.2; 2H, H-2′,6′); 7.30
(t J= 7.3; 2H, H-3′,5′); 7.20 (1H, H-4′); 2.87 (t J= 7.3; 2H, H-7′); 3.51
(q J= 6.7; 2H, H-8′); 8.61 (s 1H, NH). The description for the 13C NMR
spectrum is: 13C NMR (DMSO-d6, 125 MHz) δC134.64 (C, C-1); 127.11
(CH, C-2); 128.65 (CH, C-3); 131.04 (CH, C-4); 128.65 (CH, C-5); 127.11Scheme 1. General reaction for(CH, C-6); 139.54 (C, C-1′); 128.24 (CH, C-2′); 128.32 (CH, C-3′); 126.07
(CH, C-4′); 128.32 (CH, C-5′); 128.24 (CH, C-6′); 35.13 (CH2, C-7′);
40.90 (CH2, C-8′), 166.18 (C = O).
Animals
Adult male Swiss albinomice (Musmusculus) (25–30 g) from Feder-
al University of Piauí were used in these experiments. The animals were
maintained under controlled conditions of temperature (26 ± 1 °C)
and were fed and water ad libitum except 12 h before mitochondrial
isolation. Animal care followed the ofﬁcial governmental guidelines in
compliance with Society Policy and was approved by Ethics Committee
of Federal University of Piauí, Brazil (013/2011).
Open ﬁeld test
The open ﬁeld arena is made of acrylic (transparent walls and black
ﬂoor, 30 × 30 × 15 cm), divided into nine squares of equal areas. This
apparatus was used to evaluate the exploratory activity of the mice,
based on a previouly described model [2]. The animals were divided
into ﬁve groups (n = 8), each one received a different treatment:
diazepam (1 mg/kg, i.p), riparin A (5, 10, and 20 mg/kg, o.r.) or vehicle
(0.9% saline, o.r.). Thirty minutes after the administration of drugs was
tested, the mice were placed individually into the center of the arena
and they were allowed to explore it freely. The number of squares
crossed (with the four paws) was counted for 5 min and taken as an
indicator of locomotor activity [13].
Rota rod test
The rota rod test measures ataxia or muscle relaxation as effects
produced by drugs in animals [11]. For this test, eachmouse was placed
with all four feet onto a bar of 2.5 cm diameter, 25 cm high from the
ﬂoor, in a rotation of 17 rpm for a period of 3 min. The duration of
permanence in the swivel bar, in second(s), and the number of falls,
with three renewals at maximum were recorded [13].
Isolation of mitochondria
Mitochondria were isolated from the liver and brain of animals
according to the method described above [16].
After fasting the animals for 12 h, the mice (8 animals per group)
treated daily for 7 days with riparin A (at doses 5, 10 and 20 mg/kg)
were anesthetized with (pentobarbital 40 mg/kg; intraperitoneal) and
then euthanized for dissection and removal of the brain and liver for
mitochondrial isolation.
After the dissection of the organs, theywereweighed and immersed
in thehomogenization solution (Sucrose 125mmol/L, EDTA0.5mmol/L,
HEPES (2-[4-(2-Hydroxyethyl)-1-piperazinyl]ethanesulfonic acid):
5 mmol/L; BSA: 0.05%, pH: 7.4, temperature: 4 °C). After washing with
the solution, the organs were cut separately with a scalpel and crushed
ice in a mortar until a uniform homogenate. Homogenization solution
was added to obtain 10% homogenate, which was transferred to plastic
tubes diluted in homogenization to make the ﬁnal volume of 50 mL.
Tubes containing the homogenate were centrifuged at 4500 rpm
at 3 °C for 15 min, discarding the supernatant. Then, the tubes were
again subjected to centrifugation during 25 min at 4500 rpm. Thisthe synthesis of riparin A.
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sion and centrifugation (precipitation of mitochondria).
The pellet was resuspended supplementing the volume to 4 mL of
homogenization solution and ﬁnally the samples were homogenized
with a brush. Samples of the liver and brain were used to determine
the protein concentration applying the protocol method [24] and
mitochondria oxidative stress (lipid peroxidation level, nitrite forma-
tion, reduced glutathione content, as well as catalase and superoxide
dismutase activities).
Evaluation of oxidative stress
The samples of isolatedmitochondrial of mice treated with riparin A
(5, 10 and 20 mg/kg) and with vehicle were subjected to tests of oxida-
tive stress, as described below. The same parameters were measured
for the group treated with ascorbic acid 250 mg/kg, which was the
positive control. The evaluation of oxidative stress was performed
with ﬁve experimental groups (n = 8): a group treated with ascorbic
acid (250 mg/kg; positive control), one group treated with vehicle
(saline; negative control) and the groups treated with riparin A (5, 10
and 20 mg/kg).
Determination of lipid peroxidation levels
Lipid peroxidation levels in mice treated with riparin A (n = 8) at
doses 5, 10 and 20 mg/kg, ascorbic acid 250 mg/kg (n= 8) and vehicle
(n = 8) groups were analyzed by measuring the thiobarbituric acid
reactive substances (TBARSs) in 10% (w/v) homogenates isolated
mitochondrial of mice hepatic and brain, as previously described [10].
Brieﬂy, the samples were mixed with 1 mL 10% trichloroacetic acid
and 1 mL 0.67% thiobarbituric acid. They were then heated in a boiling
water bath for 15 min and butanol (2:1, v/v) was added to the solution.
After centrifugation (800 ×g; 5 min), thiobarbituric-acid-reacting
substances were determined from the absorbance at 535 nm. Results
were expressed as nmol of malondialdehyde (MDA)/g wet tissue [32].
Determination of nitrite content
To determine nitrite contents in mice treated with riparin A at doses
5, 10 and 20mg/kg (n= 8), ascorbic acid 250 mg/kg (n= 8) and vehi-
cle (n = 8) groups, 10% (w/v) homogenates isolated mitochondrial of
hepatic and brain frommice were centrifuged (800 ×g; 10min), super-
natants were collected and nitric oxide production was determined
based on Griess reaction [18]. Brieﬂy, 100 μL of the supernatant was in-
cubated with 100 μL of Griess reagent at room temperature for 10 min.
Absorbance was measured using a microplate reader at 550 nm. Nitrite
concentration was determined from a standard nitrite curve produced
using NaNO2. Results were expressed as μM [32].
Determination of reduced glutathione (GSH) concentration
Reduced glutathione concentration was measured in mice treated
with riparin A at doses 5, 10 and 20 mg/kg (n = 8), ascorbic acid
250 mg/kg (n = 8) and vehicle (n = 8) groups by calculating the con-
tent of non-protein sulfhydryl groups by technique previously de-
scribed in the literature [39]. 400 μL of the homogenate was added to
320 μL of distilledwater and 80 μL of trichloroacetic acid at 50%, themix-
ture was centrifuged for 15 min at 3000 rpm and then 400 μL of the su-
pernatant was taken and added to 800 μL of Tris–HCl buffer (0.4 M,
pH 8.9) and 20 μL of 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) 0,1M
and after 1 min the reading was made at 412 nm. The concentration
of GSH was expressed in nanogram per gram of tissue [32].
Determination of catalase activity (CAT)
Catalase activity was measured in mice treated with riparin A at
doses 5, 10 and 20 mg/kg (n = 8), ascorbic acid 250 mg/kg (n = 8)
and vehicle (n = 8) groups. The activity was measured by the progres-
sion of the reaction of degradation of H2O2 in H2O and O2 [9]. The stan-
dard assay substrate mixture contained 0.30 mL H2O2 in 50 mL 0.05 Msodium phosphate buffer, pH 7.0. The sample aliquot (20 μL) of 10%
(w/v) homogenates isolated mitochondrial of hepatic and brain from
mice was added to 980 μL of the substrate mixture. The initial absor-
bance was recorded after 1 min, and the ﬁnal absorbance after 6 min.
The reaction was followed at 230 nm. A standard curve was established
usingpuriﬁed catalase (Sigma, St Louis,MO, USA) under identical condi-
tions. All samples were diluted with 0.1 mmol/L sodium phosphate
buffer (pH 7.0) to induce a 50% inhibition of the diluent rate (i.e. the
uninhibited reaction). Results were expressed as mmol/min/mg of
protein [32].
Determination of superoxide dismutase (SOD) activity
Homogenates were centrifuged (800 ×g, 20 min), and the
supernants were used to assay superoxide dismutase (SOD). SOD activ-
ity in mice treated with riparin A at doses 5, 10 and 20 mg/kg (n = 8),
ascorbic acid 250 mg/kg (n = 8) and vehicle (n = 8) groups was
assayed by using xanthine and xanthine oxidase to generate superoxide
radicals [12]. Radicals react with 2,4-iodophenyl-3,4-nitophenol-5-
phenyltetrazolium chloride to form a red formazan dye. The degree
of inhibition of this reaction was measured to assess SOD activity.
The standard assay substrate mixture contained 3.0 mL xanthine
(500 μM), 7.44 mg cytochrome c, 3.0 mL KCN (200 μM), and 3.0 mL
EDTA (1 mM) in 18.0 mL 0.05 M sodium phosphate buffer, pH 7.0. The
sample aliquot (20 μL) was added to 975 μL of the substrate mixture
plus 5 μL xanthine oxidase. After 1 min, the initial absorbance was
recorded and the timer was started. The ﬁnal absorbance after 6 min
was recorded at 550 nm. SOD activity in samples was determined
from this curve and results were expressed as U/mg of protein [32].
Statistical analysis
The results were expressed as mean ± SEM (Standard Error of the
Mean). For statistical analysis, nonparametric results were analyzed by
analysis of variance (ANOVA) for multiple comparisons and Student–
Newman–Keuls as post hoc test by GraphPad Prism version 6.00 for
Windows, GraphPad Software, San Diego California USA. Copyright©
1994–1999 by GraphPad software. Differences were considered statisti-
cally signiﬁcant from p b 0.05.
Results
In this study a signiﬁcant difference in the number of crossings
in riparinA treated animals (5,10 and 20 mg/kg, respectively) was
observed when compared to the negative control (vehicle) (p N 0.05;
Fig. 1). There was a decrease in squares crossed in the group treated
with diazepam (1 mg/kg; 28.25 ± 2.21; positive control) when com-
pared with vehicle (56.25 ± 2.71) (p b 0.05; Fig. 1), due to the sedative
side effect of this benzodiazepine [13]. There was a signiﬁcant statistical
difference between groups treated with riparin A (5, 10 and 20 mg/kg)
and the positive control (p b 0.05; Fig. 1), which demonstrates that
riparin A has no signiﬁcant effect on locomotor activity.
In the rota rod test the groups treated with riparin A did not present
signiﬁcant diference in the time of permanence on the swivel bar
[5 mg/kg (163.6 ± 6.56); 10 mg/kg (164.5 ± 6.00); 20 mg/kg
(157.36 ± 5.93)] or in number of falls [5 mg/kg (1.87 ± 0.29);
10 mg/kg (2.00 ± 0.26); 20 mg/kg (2.00 ± 0.37); p N0.05], when com-
pared with vehicle (time of permanence: 171.40 ± 4.05; number of
falls: 1.87 ± 0.29), whereas when compared to the group treated with
diazepam, signiﬁcant alterations (time of permanence: 130.80 ± 6.60;
number of falls: 3.62 ± 0.37; p b0.05) were observed (Fig. 2). The
diazepam group had an increase of falls and a decrease in the time of
permanence on the swivel bar (time of permanence: 130.80 ± 6.60;
number of falls: 3.62±0.37) compared to vehicle (timeof permanence:
171.40 ± 4.05; number of falls: 1.87 ± 0.29; p b 0.05), which demon-
strates the myorelaxant effect of diazepam, whereas groups treated
with riparin A did not present impaired motor coordination.
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Fig. 1. Number of squares crossed by mice treated with diazepam (1 mg/kg) and riparin A (5, 10 and 20 mg/kg) in an open ﬁeld test. Results were expressed as mean ± SEM (n= 8 per
group). Differences among experimental groups were determined by analysis of variance (ANOVA) and t-Student–Newman–Keuls as post hoc test. ap b 0.05, when compared with
negative control (vehicle); bp b 0.05, when compared with the diazepam group.
60 G.B.L. Nunes et al. / Life Sciences 121 (2015) 57–64The oxidative stress evalution was performed in mitochondria
isolated frommice exposed to riparin A (5, 10 and 20mg/kg) regarding
lipid peroxidation levels, nitrite content, reduced glutathione (GSH)
levels, catalase activity and superoxide dismutase (SOD) activity.
Fig. 3 presents the evaluation of oxidative stress regarding lipid
peroxidation levels and nitrite content.
In hepatic mitochondria, the lipid peroxidation levels decreased by
45.1; 46.3; 36.4 and 34.3%, respectively, in animals treatedwith ascorbic
acid (250 mg/kg; positive control; 14.34 ± 1.92 nmol of MDA/g wet
tissue) and with riparin A at doses of 5 mg/kg (14.03 ± 1.28 nmol of
MDA/g wet tissue), 10 mg/kg (16.59± 1.37 nmol of MDA/g wet tissue)
and 20 mg/kg (17.15 ± 1.31 nmol of MDA/g wet tissue) when com-
pared to vehicle (negative control; 26.10 ± 1.83 nmol of MDA/g wet
tissue; p b 0.05; Fig. 3).
In brain mitochondria, the decrease of lipid peroxidation levels
was by 67.5; 41.1; 37.6 and 42.1%, respectively, in the animals treated
with ascorbic acid (250 mg/kg; positive control; 8.40 ± 0.55 nmol of
MDA/g wet tissue) and with riparin A at doses 5 mg/kg (15.31 ±
1.14 nmol of MDA/g wet tissue), 10 mg/kg (16.22 ± 1.20 nmol of
MDA/g wet tissue) and 20mg/kg (15.05± 1.15 nmol of MDA/g wet tis-
sue),when compared to vehicle (negative control; 25.98±3.44 nmol of
MDA/g wet tissue; p b 0.05; Fig. 3).When riparin A activity is compared
with ascorbic acid (250 mg/kg; positive control) signiﬁcant antioxidant
activity in hepatic and brain mitochondria is observed (p N 0.05; Fig. 3).
Fig. 3 also demonstrates a decrease in nitrite levels in hepatic mito-
chondria of mice treated with ascorbic acid (250 mg/kg; 31.61 ±
1.71 μM; positive control) and with riparin A at doses 5 mg/kg
(32.22 ± 1.19 μM), 10 mg/kg (29.81 ± 2.92 μM) and 20 mg/kgVe
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Fig. 2. Effect of the treatmentwith riparin A (5, 10 and 20mg/kg) and diazepam(1mg/kg) inm
compared to the group treated with diazepam.(28.05 ± 1.30 μM) were of 27.45; 26.07; 31.58 and 35.6%, respectively,
when compared to negative control (43.58 ± 2.88 μM), whereas in
brain mitochondria the decrease was by 47.01; 19.94; 37.35 and
75.46% in the respective groups: ascorbic acid (24.48 ± 2.47 μM);
riparin A at 5 mg/kg (36.98 ± 2.10 μM), 10 mg/kg (28.93 ± 3.72 μM)
and 20 mg/kg (11.34 ± 1.38 μM), when compared to negative control
(43.18 ± 3.29 μM p b 0.05; Fig. 3).
With regard to hepatic mitochondria, when compared to the group
treated with ascorbic acid riparin A did not present a signiﬁcant differ-
ence in reducing nitrite levels. On the other hand, brain mitochondria
with riparin A at dose 20 mg/kg presented a decrease (75.46%) which
was higher than the mean obtained with the group treated with ascor-
bic acid (47.01%; positive control; p b 0.05; Fig. 3).
Fig. 4 presents the evaluation of oxidative stress in relation to re-
duced glutathione levels.
The levels of reduced glutathione had a decrease in brain mitochon-
dria of groups treated with riparin A 5 mg/kg (73.48 ± 3.92 ng/g
protein), 10 mg/kg (76.30 ± 4.25 ng/g protein) and 20 mg/kg
(61.78 ± 10.24 ng/g protein) corresponding to 34.48; 31.96 and
44.90%, respectively, when compared to group treated with negative
control (112.1 ± 5.81 ng/g protein; p b 0.05) and 49.25; 47.30 and
57.33%, respectively, when compared with the group treated with
ascorbic acid (250 mg/kg; 144.8 ± 7.77 ng/g protein). The reduction
was also observed in the levels of GSH in hepatic mitochondria with
riparin A 5 mg/kg (47.69 ± 7.85 ng/g protein), 10 mg/kg (48.80 ±
9.87 ng/g protein) and 20 mg/kg (50.03 ± 9.22 ng/g protein), corre-
sponding to 32.87; 31.31 and 29.59%, respectively, when compared to
negative control (71.06 ± 3.38 ng/g protein; p b 0.05) and 36.80;Ve
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Fig. 3. Evaluation of oxidative stress inmitochondria isolated frommice exposed to riparin A (5, 10 and 20mg/kg) in lipid peroxidation levels and nitrite content; resultswere expressed as
mean ± SEM (n = 8 per group) (ANOVA and t-Student–Newman–Keuls as post hoc test). ap b 0.05, when compared with negative control (vehicle); bp b 0.05, when compared with
ascorbic acid group; cp b 0.05, when compared with rip A (5 mg/kg); dp b 0.05, when compared with rip A (10 mg/kg).
61G.B.L. Nunes et al. / Life Sciences 121 (2015) 57–6435.32 and 33.71% when compared to ascorbic acid (positive control;
75.46 ± 5.11 ng/g protein; p b 0.05).
Fig. 5 presents the evaluation of oxidative stress in relation to
catalase and superoxide dismutase activity.
No statistically signiﬁcant alteration was observed in antioxidant
enzymatic superoxide dismutase activity in hepatic mitochondria
treated with riparin A at any of the doses, compared both with
negative control and with ascorbic acid groups (positive control)
(p N 0.05).
In brain mitochondria riparin A at 5 mg/kg raised the enzymatic ac-
tivity of superoxide dismutase (0.93± 0.11 U/mg of protein) by 30.98%,
when compared to the group treated with vehicle (negative control;
0.71 ± 0.04 U/mg of protein; p b 0.05; Fig. 5). At the doses of 10 mg/kg
(0.74 ± 0.04 U/mg of protein) and 20 mg/kg (0.67 ± 0.04 U/mg of
protein) no signiﬁcant alterations were observed when compared with
the group treated with vehicle (negative control; p N 0.05; Fig. 5).Hepatic mitochondria
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Fig. 4. Evaluation of oxidative stress in mitochondria isolated from mice exposed to riparin A
mean ± SEM (n = 8 per group) (ANOVA and t-Student–Newman–Keuls as post hoc test). ap bCompared to the group treated with ascorbic acid (250 mg/kg; 1.05 ±
0.11 U/mg of protein), riparin A promoted a lower ezymatic activity of
superoxide dismutase, with decreases by 11.84; 29.85 and 36.49%,
respectively.
The administration of riparin A decreased the antioxidant enzymatic
activity of catalase in hepatic tissue at doses of 5 mg/kg (19.14 ± 1.70
mmol/min/mg protein), 10 mg/kg (18.34 ± 1.98 mmol/min/mg
protein) and 20 mg/kg (18.57 ± 1.54 mmol/min/mg protein) at
23.69; 26.84 and 25.92%, respectively, when compared to vehicle
(negative control; 25.07 ± 3.20; p b 0.05) and at 31.99; 34.80 and
33.98%, repectively, when compared with the group treated with
ascorbic acid (positive control; 28.14 ± 2.64 mmol/min/mg protein).
In brainmitochondria, riparin A at 5mg/kg caused a raise of antioxidant
enzymatic activity of catalase (30.42 ± 2.23 mmol/min/mg protein),
corresponding to 60% when compared to negative control (18.99 ±
1.34 mmol/min/mg protein; p b 0.05; Fig. 5).Brain mitochondria
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(5, 10 and 20 mg/kg) in relation to reduced glutathione levels; results were expressed as
0.05, when compared with negative control (vehicle).
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Fig. 5. Evaluation of oxidative stress in mitochondria isolated frommice exposed to riparin A (5, 10 and 20 mg/kg) in relation to catalase and superoxide dismutase activity. Results were
expressed as mean ± SEM (n = 8 per group) (ANOVA and t-Student–Newman–Keuls as post hoc test). ap b 0.05, when compared with negative control (vehicle).
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Oxidative stress can modify neuronal and hepatic functions and has
been linked to neurochemical alterations observed during the onset of
neurodegenerative and hepatic diseases [19,22].
Oxidative stress is particularly facilitated in the brain due to the high
oxygen utilization, generation of free radicals, insufﬁcient antioxidant
defense mechanisms, high lipid content and excitotoxicity [31]. The
liver is an organ with high metabolic activity and, therefore, is constantly
submitted to high concentrations of metabolites of drugs as well as reac-
tive oxygen species from the electron transport chain in mitochondria.
Also, these organs (the brain and liver) have a high rate of blood ﬂow,
in which minerals like iron, related to the hydroxyl radical generated
through Fenton's reaction, are in high concentration. These organs are,
thereby, notably susceptible to the damages caused by free radicals [6,48].
The brain and hetaptic tissue of mice treated with riparin A were
evaluated for degree of oxidative stress. Free radicals, such as superox-
ide, nitric oxide, and hydroxyl radical are normally produced in the
brain and liver, being converted by enzymatic antioxidant defense
systems such as superoxide dismutase and catalase [27].
Moreover, recent evidence suggests that ROS can also initiate signal-
ing cascades that respond to stress and modify speciﬁc redox-sensitive
areas as well a regulatory mechanism [47]. Thus, an antioxidant action
that promotes a reduction of deleterious effects and a control of oxida-
tive stress becomes imperative in the search of pharmacologically active
compounds.
Diazepam was used as positive control for its known sedative and
muscle relaxant effects and, despite the well documented effects of
benzodaizepines, their side effects dominate, including sedation,muscle
relaxation, anterograde amnesia and physical dependence [23]. The
comparison between the effect of riparin A and diazepam is important
to evaluate the safety and side effects of riparin A at the central nervoussystem (CNS). Diazepam has been widely used as a positive control in
studies investigating the effect of drugs on CNS [14,28,33,36].
The open ﬁeld and rota rod tests, conducted with mice treated with
riparin A, showed that, despite the substance's power to cross the blood
brain barrier, it does not produce a sedative effect, loss of motor coordi-
nation or muscle relaxation; that is, riparin A is devoid of side effects on
the CNS, possibly because it does not interact with the GABAergic
system as diazepam.
To evaluate the oxidative stress, mitochondria from the liver and
brain of mice treated with riparin A were used The mitochondrion is
the main source of free radicals, producing them as the action of cyto-
chrome oxidase controls the generation of free radicals, preventing
their excessive generation in mitochondria. However, nearly 2% to 5%
of the oxygenmetabolized in mitochondria is diverted to another meta-
bolic route and reduced to univalent form, giving rise to free radicals [5].
The thiobarbituric acid reactive substance (TBARS) levels in mice
treated with riparin A were higher than the levels found in the group
treated with ascorbic acid, but lower than the ones found in mice treat-
edwith vehicle, suggesting a potential of riparinA to avoid the oxidation
of polyunsaturated fatty acids, decrease the lipid peroxidation and pro-
tect from oxidative stress. The decrease of TBARS levels in mice treated
with riparin A did not present a dose-dependent response, indicating
that evenwith increased dose tested, reduction of TBARSwas signiﬁcant
(p b 0.05), maintaining an average (40.26 ± 1.96%) and indicating a
possible saturation of the effects of riparin A.
Reactive species of oxygen (ROS) are a part of normal humanmetab-
olism. When ROS are produced in excess, they can cause an increase in
nitrite content [21,45]. The quantiﬁcation in mice brain tissue treated
with riparin A showed a lower nitrite content compared with vehicle,
indicating that riparin A promotes the decrease of this reactive nitrogen
probably by blocking the mitochondrial disfunction and by inactivating
the enzyme nitric oxide synthase. These effects are dose-dependent, as
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nitrite 55.52% greater than that obtained with the dose of 5 mg/kg.
The nitrite content decreased in brain mitochondria from mice
treated with ascorbic acid and riparin A when compared with negative
control. The effect of riparin A in liver mitochondria was not dose-
dependent.
The possible mechanisms for the antioxidant activity of riparin A
molecule were proposed (Scheme 2), relating the chemical structure
of themoleculewith the potential to capture free radicals and inactivate
them. It was found that these compounds are very promising in antiox-
idant activity, mainly riparin A, which was capable of reducing in vitro
the levels of free radicals even in low concentrations [30].
The riparin A by its chemical structure can exercise primary antiox-
idant activity, promoting the removal or inactivation of free radicals of
reaction by donating hydrogen atoms, similar to tocopherol. The ascor-
bic acid, its isomers and derivatives are the best examples of removers
of oxygen compounds that act by capturing oxygen present in the
medium, through stable chemical reactions making them, therefore,
unavailable to act as propagators of autoxidation. Ascorbic acid can
also act as a synergist in regeneration of primary antioxidants [7].
Other substances are mentioned in the literature for their antioxi-
dant potential due to their ability to reduce lipid peroxidation level
and nitrite content, suggesting an antioxidant role in vivo since they
are able to reduce the formation of reactive species derived fromoxygen
and nitrogen [1].
The lipid peroxidation and the increase in nitrite contents caused by
oxidative stress are toxic reactions that can cause partial or total
destruction of cell membranes and cause signiﬁcant neurochemical
changes, resulting in behavior and/or motor alterations [34,37]. There
was no correlation between the locomotor activity and the decrease in
the TBARS levels produced by riparin A (r2=0.180, p=0.670). The cor-
relation between the locomotor activity and nitrite content was also
negative (r2= 0.419, p= 0.301), suggesting that reduction in lipid per-
oxidation levels and nitrite content by the treatmentwith riparin Amay
have contributed to the preservation of locomotor activity.
Substances evaluated in previous studies by similar parameters
showed an antioxidant potential similar to that obtained with riparin
A as regards the reduction of nitrite and TBARS levels. They differed,
however, in the actions exerted on the central nervous system, when
a positive correlation between the reduction of nitrite and locomotor
activitywas observed. In the studymentioned, the antioxidant potential
was associated with a simultaneous presence of sedative effect while
with riparin A the promising antioxidant activity is devoid of sedative
and muscle relaxant effects [29].
The repair of lipid peroxidation is performed by a complex process
and occurs through the action of various reducing agents of glutathione
peroxidase and glutathione reductase [40]. The decrease in TBARS pro-
duction and consequent decrease in lipid peroxidation may be related
to the decrease of GSH, without, being associated with reduction in
antioxidant capacity of the substance tested. ReducedGSH can be related
to a possible measure to maintain the redox balance of the organism.
SOD activity in brain tissuewas increased by the dose of 5mg/kg but
remained unchanged at other doses (10 and 20 mg/kg). In liver tissue
SOD activity remained unchanged in all doses tested (5, 10 andScheme 2. Antioxidant mechanism proposed for m20 mg/kg). The superoxide dismutase, the ﬁrst enzyme in removing
the superoxide anion, is found in mitochondria in MnSOD isoform,
connected to manganese ion. The SOD activity is also regulated by
reactive species and depends on the levels of reduced glutathione,
once the synthesis of the enzyme occurs by this substance [8]. Reduc-
tion of GSH can have culminated in the non-activation of SOD activity
that remained unchanged in the brain (10 and 20 mg/kg) and liver
mitochondria.
Catalase activity in brainmitochondria ofmice treatedwith riparin A
was increased mainly by the dose 5 mg/kg but was not signiﬁcantly
changed by the other doses (10 and 20 mg/kg), while in hepatic mito-
chondria, catalase activity decreased when compared with negative
control, regardeless of the dose, suggesting that the raise of the dose
cannot produce an increase of catalase enzymatic activity.
Catalase activity is carried through the use of reduced glutathione
(GSH), in a reaction catalyzed by glutathione peroxidase. After donating
electrons, GSH turns to its oxidized form (GSSG), but it can be regener-
ated by glutathione reductase by transference of hydrogen through the
reduction of nicotinamide adenine dinucleotide phosphate (NADPH)
[35]. The reduced levels of hepatic and brain GSH in mice treated with
riparin A could be related to the reduced catalase activity, while in-
creased brain enzymatic activity at the dose of 5 mg/kg can result
from immediate activation of antioxidant enzyme systems.
According to previous studies [15,17], an increase in free radical
formation is accompanied by an immediate compensatory increase in
catalase activity, which may be a long-term compensatory mechanism
including enzymatic modulation of GSH.
Considering that therewas no increase of reactive oxygen and nitro-
gen speciesin treatment with riparin A, the antioxidant enzyme modu-
lation may not have been activated, or the pro-oxidant alterations
(decrease of GSH levels and CAT activity) or not antioxidants (SOD
and CAT activities unchanged compared with negative control), can
mean a possible modulation of enzymatic activity mediated by riparin
A for CAT and SOD, altering the antioxidant defenses, which require
complementary studies to be better elucidated.
In contrast to antioxidant activity demonstrated by riparin A treat-
ment, through the decreasing in TBARS levels and nitrite content,
there is the oxidant alterations and/or the inactivation of antioxidant
activity demonstrated by the reduction in GSH levels associated with a
decrease of catalase activity and the unchanged superoxide dismutase
enzymatic activity. This suggests that the inactivation of antioxidant
activitymight be a response to promote the redox balance of the organ-
ism, since the negative changes of the enzymatic antioxidant system
were not signiﬁcant as compared to the negative control, which could
not establish oxidant levels which were able to suggest hepatotoxicity
or neurotoxicity.Conclusions
The dichotomies established in the evaluation of riparin A effect
on mice cerebral and hepatic mitochondria can be related to the
structure–activity relationship of the substance, which needs to be
further elucidated.olecule riparin A in free radical scavenging.
64 G.B.L. Nunes et al. / Life Sciences 121 (2015) 57–64There is a structurally antioxidant potential deﬁned by its capacity to
capture free radicals. This capacity is related to the presence of unstable
hydrogen in their molecules, which may have favored the reduction of
lipid peroxidation levels and nitrite content.This signals an antioxidant
potential of riparin A, coexisting with a response to promote the redox
balance of the organism, observed by negative change like the increase
of GSH, characterized by absence of enzymatic changes, or no signiﬁcant
change compared with negative control, suggesting a possible mecha-
nism of pharmacological activity of riparin A.
The riparin A presents a conceivable neuroprotective effect with
possible involvement of NO pathway. Therefore, our study suggests
that enhancement of in vivo antioxidant defenses and improvements
in the cellular antioxidant status might be an important mechanism
underlying the neuroprotective action present, making riparin as
bioactive molecule which does not produce a sedative effect, loss of
motor coordination or muscle relaxation.
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